ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IBO vs FLNA // RETURN ON INVESTED CAPITAL (ROIC)

Impact BioMedical Inc. (NYSE) VS. Filana Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: IBO 3 — FLNA 0
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: IBO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IBO VS. FLNA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IBO FLNA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -27.50% -35.00% +7.50 IBO /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.72% — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.88 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.5 42.3 +2.20 IBO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $33.1M $31.8M $1.3M IBO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IBO REV FLNA REV IBO GROSS % FLNA GROSS % IBO FCF FLNA FCF
FY 2025 $32.0K $0 -50.0% — -$1.9M -$32.8M
FY 2024 $0 $0 — — -$2.9M -$117.0M
FY 2023 $0 $0 — — -$2.9M -$82.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IBO // BETA —
FLNA // BETA —